The summary below is from the full report titled “Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction.” It is in the 20 November 2001 issue of Annals of Internal Medicine (volume 135, pages 870–883). The authors are GD Sanders, MA Hlatky, NR Every, KM McDonald, PA Heidenreich, LS Parsons, and DK Owens.
Cost-Effectiveness of Implantable Defibrillators versus the Drug Amiodarone To Prevent Abnormal Heart Rhythms after Heart Attack. Ann Intern Med. 2001;135:I–56. doi: https://doi.org/10.7326/0003-4819-135-10-200111200-00003
Download citation file:
Published: Ann Intern Med. 2001;135(10):I-56.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use